Bioanalytical input often comes too late — after protocols are finalized, timelines are squeezed, and key decisions are already set in motion. This 30-minute session highlights why that’s a costly mistake.
We’ll walk through what can go wrong when internal standards, dynamic range, and long-term stability aren’t addressed early — including real-world examples of FDA pushback and mid-study scrambles. Through two short case studies, we’ll show how early lab engagement helped teams avoid delays, cut rework, and stay on track with compliance.
Whether you're managing timelines or designing protocols, you'll walk away with clear, practical takeaways to bring the PK lab in sooner — and smarter. We’ll keep it quick, focused, and leave time for your questions
